Management of nonalcoholic steatohepatitis: an evidence-based approach.

Clin Liver Dis 2012 Aug 20;16(3):631-45. Epub 2012 Jun 20.

Storr Liver Unit, Westmead Millennium Institute, University of Sydney, New South Wales, Australia.

Nonalcoholic fatty liver disease (NAFLD) and its progressive form, nonalcoholic steatohepatitis (NASH), are an increasingly common cause of chronic liver disease in the developed world, with NASH projected to be the leading cause of liver transplantation in the United States by 2020. This review of NASH management addresses current data from the perspective of levels of evidence for therapeutic options in NASH, including lifestyle modification, drug therapies, and bariatric surgery. In particular, behavioral therapies to assist patients in adopting lifestyle changes are highlighted and a research agenda for future NASH management is presented.

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10893261120005
Publisher Site
http://dx.doi.org/10.1016/j.cld.2012.05.003DOI Listing
August 2012
1 Read

Publication Analysis

Top Keywords

liver disease
8
nonalcoholic steatohepatitis
8
nash management
8
nash
5
levels evidence
4
perspective levels
4
evidence therapeutic
4
options nash
4
nash including
4
data perspective
4
therapeutic options
4
current data
4
united states
4
transplantation united
4
liver transplantation
4
states 2020
4
2020 review
4
addresses current
4
review nash
4
including lifestyle
4

Similar Publications